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Post-exercise cardiac biomarker release has been widely reported in adult athlete groups but limited data is
available for adolescents. We assessed the impact of a 21-km run on cardiac biomarkers in adolescent athletes
and uniquely assessed N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and its potential association
with serum cardiac troponin T (cTnT) appearance. NT-pro-BNP and cTnT were measured in 17 male adolescent
runners (age, 16.5 ± 1.6 years) before, immediately after and 4 hours after a 21-km run. Post-exercise, both
cTnT (median, range: 0.12,<0.01–1.33ng·mL−1) and NT-pro-BNP (median, range: 132.6, 73.8–370.6pg·mL−1)
were elevated (p < 0.05) compared to pre-exercise (median, range: cTnT, < 0.01, < 0.01–0.02 ng·mL−1; 
NT-pro-BNP, 113.8, 39.1–240.6 pg·mL−1). There was no significant correlation between delta NT-pro-BNP
with peak post-exercise cTnT (r = 0.29, p > 0.05). Further, there was no significant difference in peak post-
exercise cTnT levels (median, range: 0.10, 0.02–1.33 vs. 0.13, 0.02–0.35 ng·mL−1, respectively, p > 0.05)
between the subjects with higher delta pre–post NT-pro-BNP values (range, 62.9–186.1 pg·mL−1, n = 8) and the
other subjects with lower delta pre–post NT-pro-BNP values (range, 8.3–55.3 pg·mL−1, n = 9). The findings
suggest that during recovery from a 21-km run, both serum cTnT and NT-pro-BNP were elevated in adoles-
cent athletes, but no significant relationship existed between increases in both biomarkers. This supports the
contention that exercise-induced cTnT and NT-pro-BNP release are largely independently mediated phenomena.
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Introduction
A growing body of evidence suggests that prolonged
strenuous exercise may induce the appearance of 
cardiac-specific biomarkers such as N-terminal pro-
brain natriuretic peptide (NT-pro-BNP) or B-type natri-
uretic peptide (BNP) and cardiac troponins (cTnT)
(Scharhag et al. 2008; Shave et al. 2007a), clinically
indicative of left ventricular dysfunction and myocyte
necrosis (Collinson et al. 2003), respectively. To date,
most available literature has studied post-exercise 
cardiac biomarker release in trained adult groups.
Data related to the cardiovascular consequences of
prolonged exercise in adolescents is extremely lim-
ited. This is despite the fact that recent reports suggest
that adolescent involvement in competitive endurance
events is increasing with case reports of both children
and adolescent runners performing greater distances
in training and competition (Roberts 2007).
The cardiac biomarker response to endurance exer-
cise in adolescents may be different to that in adults on
the basis that heart rate and total peripheral vascular
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resistance are higher than in adults (Turley 1997), sug-
gesting that myocardial work efficiency during prolonged
exercise might be reduced in adolescents (Clausen
1977). On the basis that the immature myocardium
may be more vulnerable to injury in clinical situations
(Kannankeril et al. 2002), we recently examined the
impact of a 21-km (Nie et al. 2010b), or ∼19-km (Fu 
et al. 2009), run on serum cTnT in adolescents, and
noted that the range, magnitude and positive rate of
post-exercise cTnT was greater than in previous adult
groups. These studies did not include a concomitant
assessment of NT-pro-BNP or BNP.
The relationship between BNP and cTnT has been
the target of some interest in both clinical cardiology
and sports medicine research. In clinical situations, sig-
nificant relationship might exist between increases in
NT-pro-BNP or BNP and cTnT in heart failure patients
(Sahinarslan et al. 2007), which suggests that myocar-
dial injury may be a cause of decreased cardiac func-
tion (Kociol et al. 2010). Such a relationship prompted
the assessment of both biomarkers after prolonged
exercise to investigate links between damage and dys-
function (Scharhag et al. 2008). A relationship between
exercise-associated increases in BNP and cTnT in
healthy adult athletes was reported by Ohba et al.
(2001) but could not be supported in another study for
NT-pro-BNP and cTnT (Scharhag et al. 2005). Given the
higher level of post-exercise cTnT in adolescents and
the greater potential stress in the immature myocardium
during prolonged exercise, it is apparent that addi-
tional research is required to simultaneously observe
NT-pro-BNP and cTnT in adolescents, and to elucidate
their potential relationship.
Therefore, this study was designed to assess the
impact of a 21-km run on cardiac biomarkers including
cTnT and NT-pro-BNP in adolescent athletes, and to
examine the possible relationship between changes in
the release of the two biomarkers during recovery.
Methods
Subjects
Seventeen male adolescent runners (age: 16.5 ± 1.6
years; height: 174 ± 6 cm; weight: 61.1 ± 6.4 kg; tanner
stage: 3.7 ± 1.6) who had trained for a mean period of
2.6 ± 1.0 years at a local running club and who were
performing at the national level were recruited to this
study. One week before the study, a cardiovascular
examination, including resting 12-lead electrocardio-
graphy and baseline echocardiography, was performed
in all subjects in order to identify and exclude individu-
als with potential contraindication to exercise (Maron
et al. 1996). After receiving a thorough briefing, sub-
jects and their guardians gave their written informed
consent to participate. The experiment was approved
by the local ethics committee for the use of human
and animal subjects in research.
Design
In this study, the serum cardiac biomarkers NT-
pro-BNP and cTnT were assessed at rest before and
after a 21-km run at maximal sustainable pace in all
runners. Testing occurred during the late pre-season
training period. The average training volume of the
subjects during this period was 60–100 km·wk−1 and
7–21 km·day−1 on 6 days·wk−1 basis. All subjects
were advised to abstain from hard training within the
48-hour period before pre-testing. At rest, before exer-
cise (Pre-ex), a venous blood sample was drawn. After
a short warm-up, subjects performed the 21-km run.
The 21-km run was performed on a standard 400-m
track at which the ambient temperature and relative
humidity were 7–10°C and 20–40%, respectively. After
completion of the run, subjects were asked to attend 
a testing area adjacent to the finish area as soon as
possible (time delay to onset of blood sample, 12 ± 2
minutes). Blood sampling protocols were repeated im-
mediately after the exercise (0-hr), as well as 4 hours
into recovery (4-hr).
Procedures
With subjects in a sitting position, 5 mL of venous blood
was drawn from the antecubital vein using venous
puncture. The blood was allowed to clot at room tem-
perature and then centrifuged at 2,000g for 20 minutes.
Separated serum was drawn and stored at −80°C for
later analyses. For analyses of NT-pro-BNP and cTnT,
electrochemiluminescence technology was employed
within the Elecsys 2010 automated batch analyzer
(Roche Diagnostics, Basel, Switzerland). The detection
limit of the NT-pro-BNP assay was 5 pg·mL−1. Total
imprecision for the NT-pro-BNP assay, as expressed 
by the percent coefficient of variation (CV), was
< 6.0%. An elevation of NT-pro-BNP levels is usually
significant when it exceeds the > 95th percentile of the
general population and 125 pg·mL−1 is usually consid-
ered a threshold for pathological values (Silver et al.
2004). The detection limit of the third-generation cTnT
assay was 0.01 ng·mL−1. Serum cTnT reported as
< 0.01 ng·mL−1 was represented as 0.005 ng·mL−1 (Fu
et al. 2009). For cTnT, the recommended diagnostic
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threshold according to the guidelines of the European
Society of Cardiology and American College of Cardiol-
ogy are 0.03 ng·mL−1, as precision, expressed as the
CV, was < 10%. Based on an international multicenter
clinical evaluation by construction of receiver operat-
ing characteristic curves (Collinson et al. 2003), the
cutoff for acute myocardial infarction is 0.05 ng·mL−1.
Statistical analyses
The Kolmogorov-Smirnov test was used to evaluate the
normality of the data. Due to the skewed distribution
of the biomarker data, non-parametric Friedman’s test
was used to compare NT-pro-BNP and cTnT across the
three time points (Pre-ex, 0-hr and 4-hr). Wilcoxon
signed rank test was followed for pair comparison. The
positive rates (the percentage of total subjects with 
values above the reference limits) at the three time
points were also compared with Fisher’s exact test.
Delta pre–post values for NT-pro-BNP as well as peak
post-exercise cTnT were correlated with each other, age,
baseline NT-pro-BNP and 21-km run time via Pearson’s
product-moment analysis. Further, peak post-exercise
cTnT levels were compared between the subjects (n = 9)
with higher delta pre–post NT-pro-BNP values and the
other subjects (n = 8) with lower delta pre–post NT-
pro-BNP values by Mann-Whitney test. Statistical sig-
nificance was assumed at a level of p < 0.05. Data
analyses were performed using SPSS version 11.5
(SPSS Inc., Chicago, IL, USA).
Results
All runners completed the 21-km run with an aver-
age finish time of 85.2 ± 6.2 minutes (range, 75.4–98.1
minutes). Group median, range and percent of sam-
ples above reference limits for both NT-pro-BNP and
cTnT are reported in the Table. Individual responses of 
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Table. Serum N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and cardiac troponin T (cTnT) before (Pre-ex), immedi-
ately after (0-hr) and 4 hours (4-hr) after a 21-km run in 17 adolescent runners
Pre-ex 0-hr 4-hr
NT-pro-BNP (pg·mL−1)
Median 113.8 132.6* 153.0*
Range 39.1–240.6 73.8–370.6 73.4–362.9
Positive rate (%)† 29.4 70.6* 64.7*
cTnT (ng·mL−1)
Median 0.005 0.014* 0.12*
Range 0.005–0.02 0.005–0.12 0.005–1.33
Positive rate (%)‡ 0 17.6 76.5*
*p < 0.05 vs. corresponding Pre-ex value; †percentage of subjects with serum NT-pro-BNP exceeding the clinical cutoff of 125 pg·mL−1; 
‡percentage of subjects with serum cTnT exceeding the clinical cutoff of 0.03 ng·mL−1.
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Fig. 1 Serum N-terminal pro-brain natriuretic peptide (NT-
pro-BNP) levels in 17 individual runners before (Pre-ex),
immediately after (0-hr) and 4 hours (4-hr) after a 21-km
run. The horizontal dotted line A is the clinical cutoff.
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Fig. 2 Serum cardiac troponin T (cTnT) levels in 17 individual
runners before (Pre-ex), immediately after (0-hr) and 4 hours
(4-hr) after a 21-km run. The horizontal dotted line A is the
cutoff for myocardial injury.
biomarkers at all assessment points are represented in
Figures 1 and 2. It is noteworthy that 29%of adolescent
runners had baseline NT-pro-BNP above reference lim-
its (125 pg·mL−1). Post-race increases were apparent
(p < 0.05) in both cTnT and NT-pro-BNP, although indi-
vidual responses were diverse. There was no correlation
between delta NT-pro-BNP with peak post-exercise
cTnT (r = 0.29, p > 0.05). Further, peak post-exercise
cTnT or delta NT-pro-BNP were not associated with
age (cTnT: r = 0.46, p > 0.05; NT-pro-BNP: r = −0.44,
p > 0.05), and running time (cTnT: r = 0.12, p > 0.05;
NT-pro-BNP: r = 0.37, p > 0.05). Delta NT-pro-BNP was
associated with baseline NT-pro-BNP (r = 0.54, p < 0.05)
and age (r = −0.74, p < 0.05). There was no significant
difference in peak post-exercise cTnT levels (median,
range: 0.10, 0.02–1.33 vs. 0.13, 0.02–0.35 ng·mL−1,
p > 0.05) between the subjects with higher delta pre–
post NT-pro-BNP values (range, 62.9–186.1 pg·mL−1,
n = 8) and the other subjects with lower delta pre–post
NT-pro-BNP values (range, 8.3–55.3 pg·mL−1, n = 9).
Discussion
To our knowledge, this study is the first to explore
acute responses of NT-pro-BNP to prolonged exercise
in adolescents as well as documenting its relationship
to post-exercise cTnT values. The unique finding of the
present study was that in adolescent athletes who per-
formed an “all-out” 21-km run, we observed significant
increases in the levels of serum NT-pro-BNP during
recovery. A post-exercise rise in cTnT confirms previ-
ous data. Finally, no significant relationship existed
between post-exercise elevations in NT-pro-BNP and
cTnT. This supports the contention that exercise-
induced increases in NT-pro-BNP and cTnT are likely to
be independent phenomena.
NT-pro-BNP
After prolonged and strenuous endurance exercise,
increases in NT-pro-BNP concentrations above clinical
cutoffs have been documented in adult athletes
(Scharhag et al. 2008). Increases in NT-pro-BNP have
been related to endurance exercise duration (Scharhag
et al. 2008). Scott et al. (2009) examined adult runners
during a 160-km ultramarathon race and found 
nearly a 30-fold increase in NT-pro-BNP (28 ± 17 vs.
795 ± 823 pg·mL−1). Differing results were reported by
Lippi et al. (2008) and Vidotto et al. (2005), who both
observed NT-pro-BNP to remain within the normal
range, with increases of just 100–200% after a 21-km
run in adult runners (29 ± 4 vs. 57 ± 9 and 20 ± 16 vs.
62 ± 34 pg·mL−1, respectively). To our knowledge, the
current investigation is the first to explore acute
responses of NT-pro-BNP to intense endurance exercise
in adolescent athletes. Similar to Lippi et al. (2008)
and Vidotto et al. (2005), there was a small increase in
NT-pro-BNP in the present study. We found a 50%
increase in peak NT-pro-BNP after the 21-km run
(123 ± 51 vs. 193 ± 93 pg·mL−1). However, the resting
and post-21-km-run NT-pro-BNP levels were higher in
these adolescents than in the adults reported by Lippi
et al. (2008) and Vidotto et al. (2005). Our findings do
not provide a clear explanation for the discrepancy
between adolescents and adults. Nevertheless, higher
resting NT-pro-BNP levels in healthy children, as com-
pared with adults, may play an important role in
homeostasis during the transition of the circulation from
childhood to maturity (Socrates et al. 2009). Whether
or not the higher resting NT-pro-BNP, as a marker of
myocardial growth (Socrates et al. 2009), reflects an
early myocardial adaptation to the intense endurance
training stimulus in the adolescent runners requires
further investigation.
Significant correlations were observed between
delta NT-pro-BNP and baseline NT-pro-BNP levels. Our
results confirm those observed in adults by Sahlen et al.
(2009) and Serrano-Ostariz et al. (2009) and indicate
that exercise in adolescent runners with greater resting
NT-pro-BNP values induced a greater absolute increase
in NT-pro-BNP. This has been suggested previously for
NT-pro-BNP, with possible mediation via increased age
in adults (Neumayr et al. 2005). Interestingly, we also
observed significant associations between resting NT-
pro-BNP level and the adolescents’ age. Therefore, such
findings support the contention that the same factors
that determine the resting NT-pro-BNP level, whether
physiologic, genetic or others such as age, also deter-
mine the occurrence and magnitude of NT-pro-BNP
after prolonged exercise (Sahlen et al. 2009). Similar to
other investigations in adults (Scott et al. 2009; George
et al. 2004), we found no associations between cardiac-
marker release and running time.
The significance of the observed increase in NT-
pro-BNP is poorly understood. Elevated concentrations
of NT-pro-BNP reflect elevated myocardial wall stress
due to volume or pressure overload, usually observed
within cardiac disease states (Silver et al. 2004). Con-
sequently, some authors have suggested that the 
elevated NT-pro-BNP observed following prolonged
exercise in healthy athletes is likely the response of an
acutely hemodynamically-challenged heart, rather than
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underlying pathology (Scharhag et al. 2008; Shave et al.
2007a).
cTnT
A striking finding from the current study was the high
number of detectable cTnT values witnessed in the
post-exercise samples (Table, Figure 2). Peak values
ranged from 0.02 to 1.33 ng·mL−1 (> 99th percentile,
0.01 ng·mL−1), and the resultant positive rate of 100%
(17 of 17 runners) was higher than the 47% (Fisher’s
exact test, p < 0.05) identified in the adult athletes
reported in the recent meta-analysis of 26 field-based
studies (Shave et al. 2007b). Further, 13 subjects reported
cTnT over the 0.03 ng·mL−1 criterion of myocardial
injury in the present study, and the resultant positive
rate of 77% (13 of 17 runners) was also higher (Fisher’s
exact test, p < 0.05) than that of Lippi et al. (2008) who
found no adult male runner displayed values exceed-
ing 0.03 ng·mL−1 within 24 hours following a 21-km
run. The current data more closely approaches the
findings of Middleton et al. (2008) who had a 100%
positive rate in adults performing a treadmill marathon,
likely because of the increased number of repeated
blood draws during and post-exercise that is more
likely to “catch” transient changes in cTnT during and
post-exercise.
Interestingly, Neilan et al. (2006) reported that
post-exercise alterations in cTnT were strongly influ-
enced by the level of preparation undertaken by adult
participants, i.e. the majority of most marked cTnT
increases were seen in those athletes training less than
56 km·wk−1 before a marathon race. The participants
in the current study had similar interindividual training
volume per week as the adult runners in Neilan et al.’s
(2006) study and greater training mileage than the
runners in Lippi et al.’s (2008) study (∼30 km·wk−1).
Thus, it appears that high training volumes did not act
to prevent the release of cTnT in these adolescent run-
ners. The current data also corroborates those of our
previous research in adolescent runners, in which sim-
ilar findings were displayed after a 21-km track run
(Nie et al. 2010b) and a ∼19-km treadmill run (Fu et al.
2009). Such findings seem to suggest that the release
of cTnT after exercise may be more pronounced in the
immature heart of adolescents. This requires further
systematic investigation.
The etiology and clinical significance of post-
exercise troponin release is yet to be elucidated
(Scharhag et al. 2008). Our recent animal study (Nie 
et al. 2010a) suggests that exercise-induced oxidative
stress may involve reversible cardiomyocyte membrane
leakage, leading to the leakage of cytosolic cTnT into
the circulation. Recent human evidence (Middleton
et al. 2008) also promotes the contention that cardiac
troponin release following endurance exercise might
be a physiological rather than a pathological response
in athletes.
Relationship between cTnT and 
NT-pro-BNP
The relationship between cTnT and NT-pro-BNP values
following prolonged exercise is controversial. Ohba 
et al. (2001) reported a significant relationship between
cTnT and BNP following exercise in adult athletes.
Notably though, the cTnT was measured by a first-
generation cTnT assay which is non-cardiac-specific
compared to the more specific third-generation cTnT
assay used in the present study. Whether or not the
correlation observed by Ohba et al. resulted from the
cross-reactivity between myocardial and skeletal tro-
ponin observed in the circulation after prolonged exer-
cise cannot be deduced. Some studies in adults have
reported a lack of association between the release 
of both cardiac biomarkers, measured using identical
assays to those used in the present study (Scharhag 
et al. 2005; Herrmann et al. 2003). Our data con-
curs with these studies demonstrating concomitant
increase in both biomarkers but no significant rela-
tionship between these changes. These data support
the hypothesis that alterations in cTnT and NT-
pro-BNP after prolonged exercise are largely separate
phenomena.
Limitations
In the present study, despite the fact that our findings
provide new information regarding post-exercise cardiac
biomarkers in adolescent athletes, further interpreta-
tion of the current findings is limited by some techni-
cal issues. We lack a comparison adult control group to
assess the effect of chronological age/maturation. How-
ever, matching adolescents and adults for comparison
would be very difficult. Moreover, we did not assess
cardiac function in this study, which also limits further
exploration of the relationship of cardiac function,
myocardial stress and damage. Nevertheless, our data
provide important information about trends in the bio-
chemical markers in adolescent runners during the
period of routine training that physicians may find
useful in their ‘‘routine’’ clinical evaluation. In the
future, exercise-induced increases in both cardiac bio-
markers have to be studied to elucidate the underlying
mechanisms of release.
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Conclusions
In the current study, we observed that during recovery
from a 21-km run, both serum cTnT and NT-pro-BNP
were elevated in adolescent athletes, but no relation
between increases in both biomarkers existed. These
data support the contention that exercise-induced
cTnT and NT-pro-BNP release are likely to be mediated
by independent phenomena.
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